ATE365744T1 - Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen - Google Patents

Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen

Info

Publication number
ATE365744T1
ATE365744T1 AT96928049T AT96928049T ATE365744T1 AT E365744 T1 ATE365744 T1 AT E365744T1 AT 96928049 T AT96928049 T AT 96928049T AT 96928049 T AT96928049 T AT 96928049T AT E365744 T1 ATE365744 T1 AT E365744T1
Authority
AT
Austria
Prior art keywords
peptides
protein
colon
nucleic acid
cells
Prior art date
Application number
AT96928049T
Other languages
English (en)
Inventor
Sydney Welt
Gerd Ritter
Richard Simpson
Edouard Nice
R Moritz
Bruno Catimel
Hung Ji
Antony Burgess
Joan Heath
Sara White
Cameron Johnston
Lloyd Old
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of ATE365744T1 publication Critical patent/ATE365744T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96928049T 1995-08-24 1996-08-05 Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen ATE365744T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51187695A 1995-08-24 1995-08-24
US08/597,495 US5712369A (en) 1995-08-24 1996-02-02 Isolated protein which binds to A33 antibody, and peptides corresponding to portions of the protein

Publications (1)

Publication Number Publication Date
ATE365744T1 true ATE365744T1 (de) 2007-07-15

Family

ID=27057377

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928049T ATE365744T1 (de) 1995-08-24 1996-08-05 Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen

Country Status (8)

Country Link
US (2) US5712369A (de)
EP (1) EP0851870B1 (de)
AT (1) ATE365744T1 (de)
AU (1) AU701105B2 (de)
CA (1) CA2229028C (de)
DE (1) DE69637148T2 (de)
IL (1) IL123189A0 (de)
WO (1) WO1997008189A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39760E1 (en) 1988-03-31 2007-08-07 International Bio-Immune Systems Inc. Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
US6312921B1 (en) 1996-07-26 2001-11-06 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU6537798A (en) * 1997-03-14 1998-10-12 Denise Casentini-Borocz Targeted cytolysis of cancer cells
CA2287872C (en) * 1997-05-12 2010-07-27 Aphton Corporation Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
US20040001842A1 (en) * 1997-05-12 2004-01-01 Dov Michaeli Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors
EP1241180B1 (de) * 1998-03-20 2008-07-30 Genentech, Inc. Menschliches A33-Antigen-ähnliches Protein und dafür kodierende Nukleinsäure
EP1080106A1 (de) * 1998-05-18 2001-03-07 Genetics Institute, Inc. Ausgeschiedene proteine und für diese kodierende polynukleotide
US6346249B1 (en) 1999-10-22 2002-02-12 Ludwig Institute For Cancer Research Methods for reducing the effects of cancers that express A33 antigen using A33 antigen specific immunoglobulin products
US6342587B1 (en) 1999-10-22 2002-01-29 Ludwig Institute For Cancer Research A33 antigen specific immunoglobulin products and uses thereof
JP2005508838A (ja) * 2001-03-23 2005-04-07 アフトン コーポレーション 膵癌の組合せ治療
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
AU2002326356A1 (en) * 2001-07-09 2003-01-29 Aphton Corporation Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
WO2004088326A2 (en) * 2003-03-28 2004-10-14 Aphton Corporation Gastrin hormone immunoassays
US20060020119A1 (en) * 2004-03-29 2006-01-26 Stephen Grimes Monoclonal antibodies to gastrin hormone
AT500651B9 (de) * 2003-05-27 2010-04-15 Altropus Gmbh Aktiv immunisierender antikörper
EP1794586B1 (de) 2004-09-22 2013-01-30 Cancer Advances, Inc., Monoklonale antikörper gegen progastrin
US7314622B2 (en) 2005-04-15 2008-01-01 Neogenix Oncology, Inc. Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
US20080124355A1 (en) 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
JP5710978B2 (ja) * 2007-11-08 2015-04-30 ネオジェニックス オンコロジー， インコーポレイテッド 結腸癌および膵臓癌に対する組み換えモノクローナル抗体および対応抗原
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
CA2803391C (en) 2010-06-22 2021-11-09 Neogenix Oncology, Inc. Npc1 antibodies that bind a muc5ac epitope
US9593339B1 (en) 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
KR102772810B1 (ko) 2017-06-15 2025-02-28 캔서 어드밴시스 아이엔씨 종양 및 암에 대한 체액성 및 세포 면역을 유도하기 위한 조성물 및 방법
US12285437B2 (en) 2019-10-30 2025-04-29 The Research Foundation For The State University Of New York Reversing the undesirable pH-profile of doxorubicin via activation of a disubstituted maleamic acid prodrug at tumor acidity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
PT628077E (pt) * 1992-12-10 2002-07-31 Celltech Therapeutics Ltd Anticorpos humanizados direccionados contra o antigenio de a33

Also Published As

Publication number Publication date
US5712369A (en) 1998-01-27
WO1997008189A1 (en) 1997-03-06
DE69637148D1 (de) 2007-08-09
EP0851870A1 (de) 1998-07-08
AU701105B2 (en) 1999-01-21
US6291235B1 (en) 2001-09-18
CA2229028C (en) 2008-06-10
IL123189A0 (en) 1998-09-24
DE69637148T2 (de) 2008-04-30
AU6765096A (en) 1997-03-19
EP0851870B1 (de) 2007-06-27
CA2229028A1 (en) 1997-03-06
EP0851870A4 (de) 2000-01-19

Similar Documents

Publication Publication Date Title
DE69637148D1 (de) Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen
ATE353362T1 (de) Neuartige ctla4/cd28 liganden und deren anwendungen
CY1112334T1 (el) Ομολογα πολυπεπτιδια il-17 και θεραπευτικες χρησεις αυτων
EP1053245A4 (de) 45 menschliche sekretierte proteine
ATE353365T1 (de) Neue b7-4 moleküle und deren verwendungen
ATE432983T1 (de) Mage-3 peptide, die durch hla-klasse-ii molecule presentiert werden
ATE269402T1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
SE9201331D0 (sv) Protein l och hybridproteiner daerav
ATE229977T1 (de) Peptide mit antiproliferativen eigenschaften
EA199800046A1 (ru) Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента
ATE301716T1 (de) Vmp-ähnliche sequenzen von pathogener borrelia
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
EP1015477A4 (de) 32 durch menschen ausgeschüttete proteine
WO2001036432A3 (en) 18 human secreted proteins
DE69837085D1 (de) Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
EP1042342A4 (de) 53 proteine menschlichen ursprungs
EP0815240A4 (de) Neue menschliche proteine, die cyclinebhängigen kinasen ähneln, sowie methoden zu deren verwendung
EP0369816A3 (de) Gegen menschliches polymorphes epitheliales Muzin spezifische monoklonale Antikörper
ES2150937T3 (es) Autotaxina: proteina estimulante de la motilidad util en el diagnostico y terapia del cancer.
DE69019410D1 (de) Retinoblastoma-Genprodukt-Antikörper und deren Verwendungen.
ATE302214T1 (de) Enamel-matrix bezogene polypeptide
Amiot et al. HLA class I molecules are associated with CD1a heavy chains on normal human thymus cells.
DE59410221D1 (de) Rekombinante chladosporium herbarum allergene
AU6839900A (en) Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
WO2000043419A3 (en) Exocytosis pathway proteins and methods of use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0851870

Country of ref document: EP